Firm
Colm Murphy says he is keen to help clients navigate cross-border IP challenges in Europe
With 2025 behind us, US practitioners sit down with Managing IP to discuss the major IP moments from the year and what to expect in 2026
The introduction of Canada’s patent term adjustment has left practitioners sceptical about its value, with high fees and limited eligibility meaning SMEs could lose out
With the US privacy landscape more fragmented and active than ever and federal legislation stalled, lawyers at Sheppard Mullin explain how states are taking bold steps to define their own regimes
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by Saint Island International Patent & Law OfficesTony TY Chang of Saint Island International Patent & Law Offices reviews the recent decision of the IPC Court concerning the DABUS patent application -
Sponsored by OLIVARESMauricio Sámano of OLIVARES explores how the pandemic has changed IP processes for businesses in Mexico
-
Sponsored by Adams & AdamsDanie Dohmen and Russell Bagnall of Adams & Adams, and in-house counsel Natasha Wright, consider the recent trends in pharmaceutical patent litigation in South Africa and discuss how the enforcement environment evolved during the pandemic
-
Sponsored by Gün and PartnersSelin Sinem Erciyas and Zeynep Çağla Üstün of Gün and Partners consider how far patent protection remains an obstacle to accessing COVID-19 vaccines
-
Sponsored by Adams & AdamsJenny Pienaar and Kareema Shaik of Adams & Adams consider pharmaceutical registration in the larger African markets, dealing with the challenges of registration and the subsequent enforcement of rights
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos P/S explains the EBA’s G 1/21 decision
